About the editors |
|
xv | |
Preface |
|
xvii | |
|
1 Internet of Things (IoT) and blockchain-based solutions to confront COVID-19 pandemic |
|
|
1 | (32) |
|
|
|
|
|
|
|
|
|
2 | (1) |
|
1.2 Internet of Things (IoT) and blockchain overview |
|
|
3 | (6) |
|
|
4 | (2) |
|
|
6 | (3) |
|
1.3 IoT technologies to confront COVID-19 |
|
|
9 | (5) |
|
1.3.1 Health monitoring systems |
|
|
10 | (2) |
|
1.3.2 Tracking and detecting possible patients |
|
|
12 | (1) |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
14 | (1) |
|
1.4 Blockchain technologies to confront COVID-19 |
|
|
14 | (4) |
|
|
15 | (1) |
|
|
16 | (1) |
|
1.4.3 Information sharing |
|
|
16 | (1) |
|
1.4.4 Prevention of data fabrication |
|
|
17 | (1) |
|
1.4.5 Internet of Medical Things |
|
|
18 | (1) |
|
1.5 Challenges, solutions, and deliverables |
|
|
18 | (2) |
|
1.5.1 Challenges of IoT and blockchain technology |
|
|
18 | (1) |
|
1.5.2 Possible solutions and deliverables |
|
|
19 | (1) |
|
1.6 Key findings and discussion |
|
|
20 | (1) |
|
1.7 Conclusion and future scopes |
|
|
21 | (12) |
|
|
22 | (11) |
|
2 Application of big data and computational intelligence in fighting COVID-19 epidemic |
|
|
33 | (28) |
|
|
|
|
|
34 | (2) |
|
2.2 Applicability of computational intelligence in combating COVID-19 pandemic |
|
|
36 | (4) |
|
2.3 Big data and analytics in battling COVID-19 outbreak |
|
|
40 | (4) |
|
2.4 The limitations of using big data and computational intelligence to fight the COVID-19 pandemic |
|
|
44 | (4) |
|
2.5 The practical case of using computational intelligence in fighting COVID-19 pandemic |
|
|
48 | (3) |
|
|
49 | (1) |
|
|
50 | (1) |
|
2.5.3 Precision-recall curve |
|
|
50 | (1) |
|
|
51 | (10) |
|
|
51 | (10) |
|
3 Cloud-based IoMT for early COVID-19 diagnosis and monitoring |
|
|
61 | (24) |
|
|
|
|
|
|
62 | (1) |
|
3.2 Overview about COVID-19 treatments |
|
|
63 | (3) |
|
|
63 | (1) |
|
3.2.2 Methodologies in COVID-19 diagnosis |
|
|
63 | (1) |
|
3.2.3 Treatment approaches |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
66 | (1) |
|
|
66 | (6) |
|
3.3.1 Lightweight block encryption-based secure health monitoring system for data management |
|
|
66 | (3) |
|
3.3.2 Smart diagnostic/therapeutic framework for COVID-19 patients |
|
|
69 | (1) |
|
3.3.3 IoT-based framework for collecting real-time symptom data using machine learning algorithms |
|
|
70 | (2) |
|
|
72 | (4) |
|
3.4.1 Architecture of proposed IoT framework |
|
|
73 | (3) |
|
3.4.2 Data acquisition using wearables devices |
|
|
76 | (1) |
|
3.5 Implementation of proposed framework |
|
|
76 | (2) |
|
3.6 Results and discussion |
|
|
78 | (3) |
|
3.7 Conclusion and future scopes |
|
|
81 | (4) |
|
|
82 | (3) |
|
4 Assessment analysis of COVID-19 on the global economics and trades |
|
|
85 | (30) |
|
|
|
|
86 | (1) |
|
|
87 | (1) |
|
4.3 Social impacts on finance |
|
|
88 | (1) |
|
4.4 Framework for the international financial system, bionetworks, and maintainability on pandemic |
|
|
89 | (11) |
|
4.4.1 Assessment strategy constructions to fight COVID-19 |
|
|
89 | (1) |
|
4.4.2 Macro-finance impacts |
|
|
89 | (1) |
|
4.4.3 Econometric effects: consumer preferences |
|
|
90 | (2) |
|
4.4.4 Nonpositive impacts of COVID-19 |
|
|
92 | (2) |
|
4.4.5 Impact of international commercial trading |
|
|
94 | (1) |
|
4.4.6 COVID-19's effect on the aviation industry |
|
|
94 | (2) |
|
4.4.7 Significant collision on the travel sector |
|
|
96 | (2) |
|
4.4.8 Significant reduction in primary energy usage |
|
|
98 | (1) |
|
4.4.9 Record decrease in C02 emissions |
|
|
98 | (1) |
|
4.4.10 Rise in digitalization |
|
|
99 | (1) |
|
4.5 The role of circular economy |
|
|
100 | (4) |
|
4.5.1 The circular economy for slowing the onset of climate collapse |
|
|
101 | (1) |
|
4.5.2 Social finance system |
|
|
102 | (1) |
|
4.5.3 Hurdles to CE for context of COVID-19 |
|
|
103 | (1) |
|
4.6 Chances financial support after COVID-19 |
|
|
104 | (4) |
|
4.6.1 Several solutions to manage hospital medical and general waste |
|
|
104 | (2) |
|
4.6.2 Facilities for CE in communication sector |
|
|
106 | (1) |
|
4.6.3 Use digitalization after COVID-19 |
|
|
107 | (1) |
|
|
108 | (7) |
|
|
110 | (5) |
|
5 Early diagnosis and remote monitoring using cloud-based IoMT for COVID-19 |
|
|
115 | (26) |
|
|
|
|
|
116 | (1) |
|
|
117 | (2) |
|
5.3 Internet of Medical Things |
|
|
119 | (2) |
|
5.4 IoMT devices for the identification of COVID-19 symptoms and remote monitoring |
|
|
121 | (4) |
|
|
122 | (3) |
|
5.4.2 Smartphone applications |
|
|
125 | (1) |
|
5.5 Early diagnosis of COVID-19 and remote monitoring procedures |
|
|
125 | (2) |
|
5.6 Machine learning and deep learning in COVID-19 diagnosis |
|
|
127 | (2) |
|
|
129 | (1) |
|
5.8 Experimental case study |
|
|
129 | (6) |
|
5.8.1 Dataset description |
|
|
129 | (1) |
|
|
130 | (3) |
|
|
133 | (1) |
|
5.8.4 Experimental setup and results |
|
|
134 | (1) |
|
5.9 Measures for monitoring and tracking COVID-19 |
|
|
135 | (1) |
|
5.10 Limitations of using IoMT devices |
|
|
136 | (1) |
|
5.11 Conclusion and future scope |
|
|
137 | (4) |
|
|
137 | (4) |
|
6 Blockchain technology for secure COVID-19 pandemic data handling |
|
|
141 | (40) |
|
|
|
|
|
|
142 | (2) |
|
6.2 Recent developments in blockchain technology |
|
|
144 | (7) |
|
6.2.1 Healthcare data systems |
|
|
147 | (2) |
|
6.2.2 Healthcare data exchanges |
|
|
149 | (1) |
|
6.2.3 Healthcare administration |
|
|
149 | (1) |
|
|
150 | (1) |
|
6.3 Potential benefits of blockchain technology in data handling |
|
|
151 | (3) |
|
6.3.1 Better exchange of healthcare data records |
|
|
152 | (1) |
|
6.3.2 Validating trust in medical research and supplies |
|
|
152 | (1) |
|
6.3.3 Validating correct billing management |
|
|
153 | (1) |
|
6.3.4 Internet of Things (IoT) in healthcare |
|
|
153 | (1) |
|
6.3.5 Optimized privacy and data security |
|
|
154 | (1) |
|
6.4 Key challenges of blockchain technology in data handling |
|
|
154 | (3) |
|
|
155 | (1) |
|
|
155 | (1) |
|
|
155 | (1) |
|
6.4.4 Stringent data protection regulation |
|
|
155 | (1) |
|
|
156 | (1) |
|
|
156 | (1) |
|
6.5 Prospects of blockchain technology |
|
|
157 | (3) |
|
6.6 Research on blockchain technology in COVID-19 healthcare |
|
|
160 | (3) |
|
6.7 Real-time analysis of COVID-19 pandemic data |
|
|
163 | (7) |
|
6.7.1 The susceptible recovered infectious (SIR) model |
|
|
163 | (1) |
|
6.7.2 Standard logistic regression model |
|
|
164 | (1) |
|
6.7.3 Time-to-event analytics model |
|
|
164 | (1) |
|
6.7.4 Results of major real-time analysis |
|
|
165 | (5) |
|
6.8 Recommendations and future directions |
|
|
170 | (2) |
|
6.9 Conclusion and future scopes |
|
|
172 | (9) |
|
|
173 | (1) |
|
|
173 | (8) |
|
7 Social distancing technologies for COVID-19 |
|
|
181 | (28) |
|
|
|
181 | (1) |
|
|
182 | (1) |
|
7.3 Social distancing technologies for education |
|
|
182 | (5) |
|
7.3.1 Learning management system |
|
|
183 | (3) |
|
7.3.2 Social networking and conference software for education |
|
|
186 | (1) |
|
7.4 Social distancing technology in healthcare |
|
|
187 | (6) |
|
7.4.1 Wearable technology |
|
|
187 | (1) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
189 | (2) |
|
7.4.5 Social distancing notified people in public |
|
|
191 | (2) |
|
7.5 Social distancing technology in manufacturing |
|
|
193 | (2) |
|
7.5.1 Checking the distance using wearable device |
|
|
193 | (1) |
|
7.5.2 Distance monitoring using Wi-Fi |
|
|
194 | (1) |
|
7.5.3 Distance monitoring using video analytics |
|
|
194 | (1) |
|
7.5.4 Social distancing by replacing some work with a robot |
|
|
195 | (1) |
|
7.6 Social-distancing technologies for supporting everyday life |
|
|
195 | (7) |
|
7.6.1 Technologies support working at home |
|
|
196 | (1) |
|
7.6.2 Applications support work from home (WFH) service |
|
|
196 | (4) |
|
7.6.3 Conferencing application |
|
|
200 | (2) |
|
7.7 Social distancing and smart city |
|
|
202 | (1) |
|
|
202 | (1) |
|
7.7.2 Implementation and usability |
|
|
202 | (1) |
|
7.7.3 Privacy and security |
|
|
203 | (1) |
|
7.7.4 Policy and legislation |
|
|
203 | (1) |
|
7.8 Conclusion and future works |
|
|
203 | (6) |
|
|
205 | (4) |
|
8 Social health protection in touristic destinations during COVID-19 |
|
|
209 | (18) |
|
|
|
|
|
210 | (2) |
|
|
212 | (2) |
|
8.3 Proposal of software solution for health protection |
|
|
214 | (6) |
|
8.3.1 System architecture |
|
|
215 | (2) |
|
|
217 | (1) |
|
|
218 | (1) |
|
8.3.4 Local government service |
|
|
219 | (1) |
|
|
220 | (1) |
|
|
220 | (2) |
|
8.5 Conclusion and future works |
|
|
222 | (5) |
|
|
223 | (4) |
|
9 Analysis of Artificial Intelligence and Internet of Things in biomedical imaging and sequential data for COVID-19 |
|
|
227 | (34) |
|
|
|
|
|
|
|
|
228 | (2) |
|
9.2 Definition of biomedical keywords |
|
|
230 | (2) |
|
9.2.1 Microarray and RNA-seq data |
|
|
230 | (1) |
|
|
231 | (1) |
|
|
231 | (1) |
|
|
231 | (1) |
|
9.3 Categories of computational algorithms in biomedical data |
|
|
232 | (3) |
|
9.3.1 Biomedical data analysis |
|
|
232 | (1) |
|
9.3.2 Array-based data analysis |
|
|
233 | (2) |
|
9.3.3 Hybrid data analysis |
|
|
235 | (1) |
|
9.4 Different techniques for diagnosis using biomedical imaging |
|
|
235 | (3) |
|
|
235 | (1) |
|
|
236 | (1) |
|
|
236 | (1) |
|
|
237 | (1) |
|
|
237 | (1) |
|
9.4.6 Soft tissue sarcoma |
|
|
238 | (1) |
|
9.5 Comparative review of computational algorithms |
|
|
238 | (1) |
|
9.6 Role of CT in COVID-19 pandemic |
|
|
238 | (13) |
|
9.7 Advent of smart technologies during COVID-19 |
|
|
251 | (3) |
|
9.7.1 Building ML models to diagnose COVID-19 |
|
|
253 | (1) |
|
9.7.2 Impact of IoT in healthcare |
|
|
253 | (1) |
|
|
254 | (7) |
|
|
255 | (6) |
|
10 Review of medical imaging with machine learning and deep learning-based approaches for COVID-19 |
|
|
261 | (34) |
|
|
|
|
|
262 | (2) |
|
|
264 | (15) |
|
|
264 | (15) |
|
10.3 Comparative analysis of existing work |
|
|
279 | (10) |
|
|
289 | (1) |
|
10.4.1 Unavailability of large datasets |
|
|
289 | (1) |
|
10.4.2 Imbalanced datasets |
|
|
289 | (1) |
|
10.4.3 Multiple image sources |
|
|
290 | (1) |
|
|
290 | (5) |
|
|
291 | (4) |
|
11 Machine-based drug design to inhibit SARS-CoV-2 virus |
|
|
295 | (36) |
|
|
|
|
|
|
296 | (2) |
|
11.2 What is SARS-coronavirus-2? |
|
|
298 | (1) |
|
11.3 Mechanism of SARS-coronavirus-2 infection in human |
|
|
299 | (1) |
|
11.4 How SARS-coronavirus-2 multiplies? |
|
|
300 | (2) |
|
11.5 Human antibody generation and role of vaccine |
|
|
302 | (1) |
|
11.5.1 Immediate action of human antibody |
|
|
302 | (1) |
|
11.5.2 Role of synthetic vaccine on COVID-19 |
|
|
302 | (1) |
|
11.6 Real-time COVID-19 identification test (RT-PCR) |
|
|
303 | (2) |
|
11.6.1 Limitations of RT-PCR tool |
|
|
304 | (1) |
|
11.7 Discussion on in silico methods in COVID-19 drug research |
|
|
305 | (13) |
|
11.7.1 In silico-assisted anchoring site analysis |
|
|
305 | (2) |
|
11.7.2 Machine-assisted designing and evaluation of COVID-19 drug |
|
|
307 | (11) |
|
11.8 Machine-integrated advanced techniques for COVID-19 |
|
|
318 | (4) |
|
11.8.1 Computerized tomography in COVID-19 detection |
|
|
318 | (1) |
|
11.8.2 Advanced MRI for COVID-19 treatment |
|
|
319 | (3) |
|
|
322 | (2) |
|
11.10 Conclusion and future scopes |
|
|
324 | (7) |
|
|
324 | (1) |
|
|
325 | (6) |
|
12 Stress detection for cognitive rehabilitation in COVID-19 scenario |
|
|
331 | (28) |
|
|
|
|
|
331 | (2) |
|
|
333 | (2) |
|
|
335 | (9) |
|
12.3.1 Introduction to EEG |
|
|
340 | (1) |
|
12.3.2 Feature extraction using DWT |
|
|
341 | (1) |
|
12.3.3 Feature selection using principal component analysis |
|
|
342 | (1) |
|
12.3.4 Classification using support vector machine |
|
|
343 | (1) |
|
12.4 Experimental outcomes and discussions |
|
|
344 | (7) |
|
12.4.1 Dataset preparation |
|
|
344 | (1) |
|
12.4.2 Sloreta-based activated brain region selection |
|
|
345 | (1) |
|
12.4.3 Discrete wavelet transform-based feature extraction outcome |
|
|
345 | (1) |
|
12.4.4 Principal component analysis-based dimensionality reduction outcome |
|
|
346 | (1) |
|
12.4.5 Support vector machine-based classification outcome |
|
|
346 | (2) |
|
12.4.6 Performance metrics |
|
|
348 | (1) |
|
12.4.7 Performance evaluation |
|
|
348 | (2) |
|
12.4.8 Statistical significance using Mest |
|
|
350 | (1) |
|
12.5 Conclusion and future works |
|
|
351 | (8) |
|
|
351 | (1) |
|
|
352 | (7) |
|
13 Arduino-based robot for purification of COVID-19 using far UVC light |
|
|
359 | (26) |
|
|
|
|
|
360 | (5) |
|
|
360 | (3) |
|
|
363 | (2) |
|
|
365 | (11) |
|
13.2.1 Improvements and requirements |
|
|
372 | (4) |
|
13.3 Working of the proposed robot |
|
|
376 | (2) |
|
|
377 | (1) |
|
13.4 Results and discussions |
|
|
378 | (3) |
|
13.5 Conclusion and future scope |
|
|
381 | (4) |
|
|
381 | (4) |
|
14 Effect of COVID-19 pandemic on waste management system and infection control |
|
|
385 | (20) |
|
|
|
|
386 | (1) |
|
14.2 Socioeconomic and environmental impact |
|
|
387 | (1) |
|
14.3 Impact of waste generation |
|
|
388 | (2) |
|
14.4 Impacts on waste management |
|
|
390 | (3) |
|
14.4.1 Waste management adjustments |
|
|
392 | (1) |
|
14.5 Challenges in handling waste |
|
|
393 | (1) |
|
14.6 Rethinking effective waste management |
|
|
394 | (3) |
|
14.6.1 Policy, regulatory, and guidelines |
|
|
395 | (1) |
|
14.6.2 Handling of infectious waste |
|
|
395 | (1) |
|
14.6.3 Suitable disposal methods |
|
|
396 | (1) |
|
14.6.4 Information, education, and communication |
|
|
396 | (1) |
|
14.6.5 Data management and learning |
|
|
396 | (1) |
|
14.6.6 Monitoring of segregation |
|
|
396 | (1) |
|
14.6.7 Basic principles for managing waste |
|
|
396 | (1) |
|
14.6.8 Fund raising and national and international collaboration |
|
|
397 | (1) |
|
14.7 Conclusion and future scopes |
|
|
397 | (8) |
|
|
398 | (7) |
|
15 Natural adjunctive therapies options other than COVID-19 antiviral therapies |
|
|
405 | (16) |
|
|
|
|
406 | (1) |
|
15.2 Immune system and inflammatory responds |
|
|
407 | (1) |
|
15.3 Proinflammatory cytokines |
|
|
408 | (1) |
|
15.4 Immunomodulators and adjunctive therapies |
|
|
409 | (6) |
|
15.4.1 Phenolic compounds |
|
|
409 | (3) |
|
|
412 | (1) |
|
|
413 | (1) |
|
15.4.4 Ascorbic acid (vitamin C) |
|
|
413 | (1) |
|
|
413 | (1) |
|
|
414 | (1) |
|
|
414 | (1) |
|
15.4.8 Omega-3 fatty acids |
|
|
414 | (1) |
|
15.5 Dietary ingredients in immunity |
|
|
415 | (1) |
|
15.6 Conclusion and future scope for natural antiviral therapies against COVID-19 |
|
|
415 | (6) |
|
|
415 | (6) |
|
16 Risk assessment and spread of COVID-19 |
|
|
421 | (18) |
|
|
|
|
|
|
422 | (1) |
|
16.2 Technology and epidemics |
|
|
422 | (4) |
|
|
425 | (1) |
|
|
425 | (1) |
|
|
425 | (1) |
|
|
425 | (1) |
|
16.3 Prediction techniques |
|
|
426 | (1) |
|
16.4 General methods followed for risk assessment |
|
|
427 | (4) |
|
|
428 | (1) |
|
16.4.2 Fault-tree analysis |
|
|
429 | (1) |
|
16.4.3 Guidelines issued by World Health Organization |
|
|
430 | (1) |
|
16.5 Prevention and management of epidemics |
|
|
431 | (3) |
|
16.5.1 Strategies proposed |
|
|
432 | (1) |
|
16.5.2 Sentimental analysis using machine learning |
|
|
433 | (1) |
|
16.6 Protecting the living beings from the impact of epidemics |
|
|
434 | (1) |
|
16.6.1 Impact of COVID-19 on agriculture sector |
|
|
434 | (1) |
|
16.6.2 Impact of COVID-19 on economy |
|
|
434 | (1) |
|
16.6.3 Impact of COVID-19 on educational sector |
|
|
435 | (1) |
|
|
435 | (3) |
|
16.7.1 Proposed method and its working |
|
|
435 | (1) |
|
16.7.2 Components required |
|
|
436 | (1) |
|
16.7.3 Software required and simulation |
|
|
437 | (1) |
|
16.8 Conclusion and future scope |
|
|
438 | (1) |
References |
|
439 | (4) |
Index |
|
443 | |